Skip to main content
All lobbying filings

STANTON PARK GROUP

Lobbying for MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
Texas

Official filing document

 Lobbyists on this filing 5
  • BRYAN WILLIAM WELLS
    Previously held: Policy Advisor, Senator Pat Roberts
  • AISLING MCDONOUGH
    Previously held: Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz
  • KEVIN DAWSON New on this filing
    Previously held: Chief of Staff, Congressman Mike Kelly; Health Policy Advisor, Senator Bill Cassidy; Professional Staff Member, Senate Committee on the Budget
  • JAMES DERDERIAN
    Previously held: Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley
  • VALERIE HENRY
    Previously held: Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
  • HR 2484
    Seniors’ Access to Critical Medications Act of 2025
 Lobbying activity 2
Medicare/Medicaid

Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain; HR4299, Protecting Patient Access to Cancer and Complex Therapies Act.

Health Issues

H.R.2484, Seniors Access to Critical Medications Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem